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 Advanced Therapy in Traumatic Brain Injury Inpatient Rehabilitation: Effects on 1 
Outcomes During the First Year after Discharge 2 
Abstract 3 
 4 
Objective: To use causal inference methods to determine if receipt of a greater proportion 5 
inpatient rehabilitation treatment focused on higher level functions, e.g. executive functions, 6 
ambulating over uneven surfaces (Advanced Therapy, AdvTx) results in better rehabilitation 7 
outcomes.  8 
Design: A cohort study using propensity score methods applied to the TBI-Practice-Based 9 
Evidence (TBI-PBE) database, a database consisting of multi-site, prospective, longitudinal 10 
observational data. 11 
Setting: Acute inpatient rehabilitation (IRF). 12 
Participants: Patients enrolled in the TBI-PBE study (n=1843), aged 14 years or older, who 13 
sustained a severe, moderate, or complicated mild TBI, receiving their first IRF admission to one 14 
of 9 sites in the US, and consented to follow-up 3 and 9 months post discharge from inpatient 15 
rehabilitation. 16 
Interventions: Not applicable. 17 
Main Outcome Measures: Participation Assessment with Recombined Tools-Objective-17, 18 
FIMTM Motor and Cognitive scores, Satisfaction with Life Scale, and Patient Health 19 
Questionnaire-9. 20 
Results: Controlling for measured potential confounders, increasing the percentage of AdvTx 21 
during inpatient TBI rehabilitation was found to be associated with better community 22 
participation, functional independence, life satisfaction, and decreased likelihood of depression 23 
during the year following discharge from inpatient rehabilitation.  Participants who began 24 
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rehabilitation with greater disability experienced larger gains on some outcomes than those who 25 
began rehabilitation with more intact abilities.   26 
Conclusions: Increasing the proportion of treatment targeting higher level functions appears to 27 
have no detrimental and a small, beneficial effect on outcome. Caution should be exercised when 28 
inferring causality given that a large number of potential confounders could not be completely 29 
controlled with propensity score methods.  Further, the extent to which unmeasured confounders 30 
influenced the findings is not known and could be of particular concern due to the potential for 31 
the patient’s recovery trajectory to influence therapists’ decisions to provide a greater amount 32 
AdvTx. 33 
 34 
Abbreviations: 35 
AdvTx  Advanced Therapy 36 
ASD  Absolute standardized difference 37 
CSI  Comprehensive Severity Index 38 
FIM  Functional Independence Measure  39 
HTE  Heterogeneity of treatment effect 40 
IPW  Inverse probability weighting 41 
OT  Occupational therapy 42 
PART-O Participation Assessment with Recombined Tools-Objective 43 
PHQ-9  Patient Health Questionnaire-9 44 
POC  Point of care 45 
PSM  Propensity score methodology 46 
PT  Physical therapy 47 
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RCT  Randomized controlled trial 48 
SDC  Supplemental digital content 49 
ST  Speech therapy 50 
SWLS  Satisfaction with Life Scale 51 
TBI  Traumatic brain injury 52 
TBI-PBE Traumatic brain injury Practice Based Evidence study 53 
TR  Therapeutic recreation 54 
 55 
Conventional rehabilitation theories are based on the assumption that a hierarchical sequence of 56 
recovery steps must be followed to restore normal function, and challenging patients too quickly 57 
or encouraging compensatory strategies too early is seen as a wasted effort, if not potentially 58 
counterproductive.1-3   These “bottom-up” approaches, including neurodevelopmental treatment 59 
(e.g. the Bobath approach1 ) in motor rehabilitation and restorative techniques in cognitive 60 
rehabilitation4 , assume underlying component skills or functions must first be restored before 61 
more complex functions can be addressed successfully. However, recent perspectives reflect an 62 
evolution of ideas that recognize the dynamic system’s complexities and inter-relationships 63 
between functional abilities, neuroplasticity, and psychological factors, such as engagement and 64 
motivation. For instance, Winstein and Kay5  posit that effective rehabilitation must engage and 65 
empower the individual, and to do so requires the active ingredients to be:  1) challenging; 2) 66 
progressively increasing in level of difficulty; and 3) intrinsically motivating and engaging. 67 
Likewise, recent recommendations in cognitive rehabilitation take a pragmatic perspective, 68 
introducing compensatory strategies earlier rather than later and thereby allowing the individual 69 
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to engage in more advanced activities, even if some of the underlying functions have not been 70 
restored.6   71 
 72 
These differing perspectives continue to co-exist in the literature.7-10  Unfortunately, there is a 73 
dearth of empirical evidence to guide a clinician’s decision-making as to when to provide 74 
challenging interventions, compensatory activities, and metacognitive strategies in TBI inpatient 75 
rehabilitation. The evidence that does exist is based on applications in alternative settings and 76 
with different levels of acuity. For example, a recent meta-analysis supported the initiation of 77 
intensive rehabilitation in the ICU to improve outcomes following severe traumatic brain injury 78 
(TBI).8   However, the therapeutic activities studied targeted lower level functions, such as 79 
following commands and increasing awareness of the environment. At the other end of the 80 
continuum, compensatory and metacognitive strategies have been found effective for improving 81 
executive functioning, however most studies have been conducted in outpatient settings with 82 
patients many months post-injury.7  The effect of introducing strategy training in the more acute 83 
stages of rehabilitation has received minimal investigation. 84 
 85 
Recent findings from studies of stroke rehabilitation support the use of therapeutic interventions 86 
that target functions at a substantially higher level than the patient’s current level of ability.9  87 
Practice-based evidence studies with patients who had a stroke have found that therapy that 88 
challenges patients with severe impairments, such as therapies targeting advanced gait 89 
(negotiating uneven surfaces), home management, and problem-solving, were associated with 90 
better outcomes than therapies targeting lower level functions such as bed mobility.11,12  The 91 
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authors of these studies conclude from these findings that a “leap-frog” approach that introduces 92 
challenge earlier rather than later is necessary for neuroplasticity and effective rehabilitation. 93 
 94 
The TBI Practice-Based Evidence (PBE) study yielded findings similar to those found for the 95 
stroke population.13-15  Differences in difficulty levels of therapy activities during inpatient 96 
rehabilitation added substantial variance to the prediction of TBI outcomes at rehabilitation 97 
discharge, with some of the most beneficial activities targeting relatively more advanced 98 
functions. Participants with the greatest cognitive impairments were among those who appeared 99 
to benefit most.  100 
 101 
The purpose of the current study is to extend the previous studies by evaluating the effects of 102 
receiving a greater proportion of Advanced Therapy (AdvTx) using causal inference methods16,17  103 
and a multidisciplinary treatment classification system of AdvTx. The amount of AdvTx was 104 
determined by therapist discretion, environment, and other factors.  For cognitive abilities, the 105 
targets of AdvTx were higher-level executive functions and the independent use of compensatory 106 
strategies with complex tasks. For physical abilities, the targets included capacity to manage 107 
unintended perturbation and skilled learning. The management of challenges within a changing 108 
environment, including distractions and physical barriers, were included in this definition. The 109 
functions targeted by rehabilitation fall along a continuum from more basic to the most 110 
advanced; for the purposes of this study we included functions and abilities at the extreme end of 111 
the continuum to ensure that the interventions are challenging for all patients, even those who 112 
presented with less severe disability at admission to rehabilitation. 113 
 114 
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The current study then evaluates the effects of the ‘dose’ of AdvTx relative to non-advanced.   115 
We hypothesized that when a greater proportion of therapists’ time is spent providing AdvTx, 116 
patients achieve better outcomes.  We also hypothesized that patients who presented to 117 
rehabilitation with the greatest amount of disability, and who were therefore most challenged by 118 
the AdvTx, would experience greater benefit from a higher proportion of AdvTx than those who 119 
presented with less severe disability.  120 
 121 
METHODS 122 
Participants. The Participant Flow Diagram for this cohort study can be found in supplemental 123 
digital content (SDC).  A cohort of 1843 participants was drawn from the TBI-PBE Database 124 
(n=2120).14  The criteria for inclusion in the current analysis were that the participant received 125 
their first course of rehabilitation for complicated mild, moderate, or severe TBI from one of 9 126 
US sites during the recruitment and data collection period (2008-2011), consented to follow-up, 127 
received therapy after the initial assessment period (first 3 days of admission to rehabilitation) 128 
and was age 14 years or older.   Institutional review board approval was obtained by the sites that 129 
participated in the original TBI-PBE study. 130 
 131 
For the purposes of evaluating heterogeneity of treatment effects (HTE) the sample was divided 132 
into two subgroups. The Severe Group consisted of 820 patients who presented to rehabilitation 133 
requiring total or maximal assistance with all self-care needs (operationalized as FIM Motor < 134 
28.75 and FIM Cognitive scores < 15). The Less Severe Group consisted of the remainder of the 135 
sample (n=1023). 136 
 137 
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Data source for the intervention. As part of the original TBI-PBE study14 , point of care (POC) 138 
forms and associated syllabi were developed by discipline-specific committees for occupational 139 
therapy, physical therapy, speech therapy, and therapeutic recreation (OT, PT, ST, TR). 140 
Therapists recorded the time spent in various treatment activities in each session on POC forms. 141 
Data collection quality was supported through a comprehensive quality assurance program.  142 
 143 
As part of the current study, representatives from each discipline reviewed tables of treatment 144 
activities. Using the definition of AdvTx provided earlier, they identified those session 145 
components that met the definition. In a few instances, where the interpretation of the syllabus 146 
text was unclear, therapists outside of the research team were contacted to answer questions as to 147 
how they would classify the activity and/or intervention.  See SDC for graphics illustrating the 148 
classification system.    149 
The percentage of total therapy time spent in AdvTx was calculated, with the numerator equaling 150 
therapy minutes spent in AdvTx, and the denominator equaling all therapy minutes. The 151 
distribution of the proportion of time spent in AdvTx was slightly skewed, with a mean of 152 
16.16% (SD=12.14) and median of 14.15%. The analysis compared outcomes of patients who 153 
received different proportions of time in AdvTx. 154 
 155 
Outcomes. Data on outcomes were collected at discharge and at 3 and 9 months post-discharge.  156 
The primary outcome was community participation, as measured by the Participation 157 
Assessment with Recombined Tools-Objective (PART-O-17) at 9 months.18,19  The PART-O-17 158 
includes three subtests: Productivity, Being Out-and-About, and Social Relations. Test-retest 159 
reliability has been established20  and studies of validity have focused on dimensionality and 160 
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relationships with other measures and constructs.21-24  In addition to a Total score that reflects the 161 
average of the 3 domain scores, an alternative method for calculating a unidimensional 162 
participation score has been developed based on Rasch analysis.24  Since the two summary 163 
scores characterize the construct slightly differently, both the PART-O Rasch Total score and the 164 
original Total score were used in this study, along with the three domain scores. 165 
 166 
Secondary outcomes included: functional independence as measured by the FIMTM Motor and 167 
Cognitive Rasch-converted scores25-28 ; life satisfaction as measured by the Satisfaction with Life 168 
Scale (SWLS);29 and depression as measured by the Patient Health Questionnaire-9 (PHQ-9). 30 169 
All of these measures have established reliability and validity for use with persons with TBI. 170 
18,21,23,24,31-36
 
 The PHQ-9 was analyzed as a dichotomous variable: likely major depression vs. no 171 
major depression.36  When the person with TBI was not able to complete the follow-up, the 172 
SWLS and PHQ-9 were not administered and the FIM and PART-O-17 were based on a proxy 173 
report.  174 
 175 
Potential confounders. Since the purpose of the study was to examine the potential effectiveness 176 
of AdvTx, other potential predictors of these outcomes were considered confounders and 177 
controlled through propensity score methodology. Data on premorbid history, injury 178 
characteristics, and functioning at admission to rehabilitation were abstracted from rehabilitation 179 
medical records. Only variables that were unlikely to be influenced by treatment received in 180 
inpatient rehabilitation were considered as potential confounders, and therefore only those that 181 
were measured prior to treatment or at rehabilitation admission (first 3 days), were included in 182 
the propensity score model (admission assessments are conducted during the first 3 days of 183 
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rehabilitation15 ). In addition to more traditional measures of severity, we used the 184 
Comprehensive Severity Index (CSI®)11,37,38  Brain Injury and Non-Brain Injury scores to 185 
represent the complex interactions between physiological and psychological phenomena that 186 
contribute to disease.14   We grouped sites by the typical length of their therapy sessions, with 187 
shorter session sites having a mean of .56 hours (SD .06) and longer session sites having a mean 188 
of .71 hours (SD .06).  189 
 190 
Analysis.  Data were analyzed using SAS v9.3a and STATA version 14.0b. Potential confounders 191 
were controlled using inverse probability weighting (IPW) based on a generalized propensity 192 
score. The proportion of AdvTx was allocated evenly across 10 quantiles or bins (5 bins were 193 
used when the sample was stratified due to smaller n). A cumulative logistic model was used to 194 
estimate the predicted probability of being in each quantile, and inverse probability weights 195 
constructed.39 Multiple models were evaluated, including evaluation of interaction terms, until it 196 
was determined that the best possible balance was achieved. Participants with extreme weights 197 
(>10) or who were dropped from the generalized propensity score models were not included in 198 
subsequent analyses (n=17). The average absolute standardized difference (ASD) between all 199 
pairs of quantiles was calculated; if the ASD for a potential confounder exceeded .10 (a 200 
conservative threshold), the potential confounder was considered not to be sufficiently balanced 201 
by the weighting and considered for inclusion in the adjusted models used for the outcome 202 
analysis.40,41  However, if the number of possible covariates threatened the stability of the model, 203 
covariates were also chosen based on a) content knowledge indicating which covariates were 204 
most influential and b) the distribution of the covariates (those that had sparse cells were not 205 
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included).  Since an ASD < .20 is often considered sufficient to indicate balance42 , covariates 206 
with ASD > .20 were of greatest concern. 207 
 208 
The hypothesis that a higher proportion of AdvTx would be associated with better outcomes was 209 
evaluated through marginal regression models with robust sandwich error estimates. The first 210 
step included only AdvTx in the model; the next step added those confounders that did not meet 211 
the criterion for achieving sufficient balance through IPW. We assessed the impact of missing 212 
outcome data through the use of multiple imputations to simulate a complete sample, and then 213 
comparing results to those obtained with the sample for which the outcome data were complete. 214 
Multiple imputation models by chained equations (MICE), with predictive mean matching for 215 
continuous outcomes and K-nearest neighbors for categorical variables, included all outcomes, 216 
treatments and covariates explored between the treatment exposures and outcomes.   217 
 218 
The extent that severity of initial disability modified the effect of AdvTx was tested with an 219 
interaction term (Severity*AdvTx). In addition, we evaluated whether results changed when the 220 
Severe and Not Severe subgroups were analyzed as separate strata. 221 
 222 
Results 223 
Table 1 lists key covariates describing the sample and the quantile distributions before and after 224 
weighting (a table with all 75 covariates appears in SDC). Prior to weighting, ASD ranged from 225 
.03-.79, with an average ASD of .17.  After weighting, ASD ranged from .05 to .30, with an 226 
average ASD of .11; 40 covariates had an average ASD > .10.  While there was a large number 227 
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of covariates with ASD >.10, only 3 exceeded .20 (FIM Motor, FIM Cognitive, and days from 228 
injury to rehabilitation admission) and the maximum average ASD was still relatively low. 229 
 230 
Prior to adjustment for the 40 unbalanced confounders, increasing the proportion of time in 231 
AdvTx was found to be associated with better community participation at both 3 and 9 months 232 
for the total scores (PART-O Total, PART-O Rasch Total) and most domain scores (PART-O 233 
Out-and-About at 9 months, Productivity, and Social Relations at 3 and 9 months). In addition, 234 
positive effects were observed for functional independence (FIM Cognitive and Motor) at 235 
discharge, 3 and 9 months (p<.05, see Table in SDC). Following adjustment for unbalanced 236 
covariates, the effects were somewhat attenuated, but more precise. As shown in Table 2, 237 
findings remained significant for the PART-O total scores, Productivity at 3 and 9 months, Out-238 
and-About at 9 months, FIM Cognitive and Motor, and estimates became stronger for SWLS (9 239 
months only) and PHQ-9 at 3 and 9 months (odds for depression decreased by 3% at each time 240 
point). No substantive differences in inference were noted following multiple imputation of 241 
outcomes. 242 
 243 
HTE for initial level of disability. The interaction term for initial level of disability and 244 
proportion of AdvTx was used to assess HTE. Cumulative logistic regression models estimated 245 
the generalized propensity scores on the full cohort, with refinement to achieve balance by 246 
severity groups across 5 quantiles. Prior to IPW, the mean ASD for the Severe subgroup ranged 247 
from .04 to .57, averaging .18; after IPW, the ASD ranged from .03 to .36, averaging .14, with 55 248 
covariates having ASD> .10 (11 covariates with ASD> .20). Prior to IPW, for the Less Severe 249 
subgroup ASD ranged from .03 to .63, averaging .17.  After IPW, the ASD ranged from .06 to 250 
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.29, averaging .15 with 62 covariates > .10 (15 covariates with ASD > .20). Since the combined 251 
number of covariates that did not meet the criterion of ASD <.10 was too large to include in the 252 
outcome analysis, the covariates were selected based on additional decision parameters (i.e. 253 
content knowledge, sparseness of cells).  254 
 255 
Prior to adjustment for unbalanced covariates, the interaction term (Severity*AdvTx) was 256 
significant for FIM Cognitive and Motor scores, at all time points. No other outcomes showed 257 
significant interaction effects. After adjusting for unbalanced covariates, the effects were 258 
somewhat attenuated but remained significant for FIM Cognitive and Motor (Table 3).  Those 259 
who presented with severe disability at admission appeared to experience more benefit from 260 
AdvTx on these two outcome variables, and no significant differences were observed on the 261 
other outcome variables. 262 
 263 
We evaluated whether findings changed when the subgroups were analyzed separately. For the 264 
Severe group, prior to IPW the ASD ranged from .03 to .51, averaging .17. After IPW the ASD 265 
ranged from .05-.30, averaging .13 with 54 covariates with ASD > .10 (8 with ASD>.20). Prior 266 
to IPW, ASD for the Less Severe group ranged from .03 to .57, averaging .16.  After IPW, it 267 
ranged from .03 to .20, averaging .10, with 29 covariates with ASD >. 10 (1 covariate with ASD 268 
> .20). Using the models adjusted for unbalanced covariates (SDC Table), the Severe subgroup 269 
experienced greater benefits from greater proportion of AdvTx than the Less Severe subgroup 270 
on: FIM Cognitive and Motor (all time points), and PART-O Rasch Total, and Productivity at 3 271 
months. These findings are generally consistent with those found using the interaction term. 272 
 273 
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Discussion 274 
The current findings suggest therapeutic activities during acute inpatient TBI rehabilitation 275 
targeting the highest level functions in the physical and cognitive realms are associated with 276 
better community participation, functional independence, life satisfaction, and decreased 277 
likelihood of depression during the year following discharge from inpatient rehabilitation. 278 
Furthermore, participants who begin rehabilitation with greater disability experience larger gains 279 
on some outcomes than those who begin rehabilitation with more intact abilities.   280 
 281 
The current findings are consistent with the previous TBI-PBE studies.13 15 43   This consistency 282 
implies that the construct (AdvTx continuum) is relatively robust in the context of different 283 
operational definitions.  The previous studies used a method for classifying treatment that 284 
differed from the current operational definition in three key ways: 1) previous studies defined 285 
‘advanced’ activities relative to other activities within a discipline, rather than across disciplines; 286 
2) to increase the likelihood that activities chosen as advanced were challenging for everyone, 287 
only the most challenging activities were designated as advanced in the current study; and 3) the 288 
current study used multiple sources of information from the POC forms (e.g. activities, 289 
interventions, targeted functions) while the previous studies only used information on activities.   290 
 291 
Taken together, the findings support the notion that challenging patients to perform functions 292 
above their current level can spur recovery. As noted by Winstein and Kay5  in their synthesis of 293 
the neuroplasticity and stroke rehabilitation literatures, cortical reorganization has been found to 294 
be dependent upon active problem-solving, challenges that are progressively more difficult, and 295 
engagement of the patient. While the current study design does not allow a direct assessment of 296 
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the degree to which the activities were “progressively more difficult” for the individual patient, 297 
by definition AdvTx activities involved higher-level problem solving and the ability to adapt to a 298 
changing environment. In addition, patients were taught how to use compensatory strategies to 299 
perform more complex activities required for community integration, presumably facilitating 300 
patient engagement.  301 
 302 
The observed effect sizes were relatively small, though meaningful. For example, using the 303 
PART-O Total Rasch-transformed score, increasing the proportion of AdvTx by 20% (e.g. 10% 304 
AdvTx to 30%) could increase the number of days out of the house in a week from 1-2 days to 305 
5+ days at 9 months post-discharge. During an exercise to evaluate meaningful changes on the 306 
outcome measures, consumer stakeholders involved in the project indicated that even smaller 307 
changes (e.g. getting out of the house or socializing with friends one more time per week) were 308 
important. They noted that a small change in one area can prompt change in other, non-measured 309 
areas as well. 310 
 311 
Winstein and Kay’s5  recommendation that therapy be “difficult, but not too difficult” should be 312 
kept in mind when applying the results of this study.  The application of the findings to the 313 
practice of rehabilitation will need to take into account patients’ level of functioning and factors 314 
that may impede their ability to participate in AdvTx, such as fatigue or pain. The potential risk 315 
for patients’ safety will also need to be evaluated. Therapist and environmental factors may also 316 
influence the extent to which AdvTx can be consistently delivered across patients, given current 317 
demands on therapists to minimize preparation time and to see an increasing number of patients. 318 
 319 
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Limitations.  Several limitations should be considered in interpreting and applying the study 320 
findings. This study may not represent all individuals receiving rehabilitation  and only assesses 321 
the relationship of Advance Therapy during acute inpatient rehabilitation, not at later time points.   322 
We used multiple imputation to assess the impact of missing outcomes on the results; it is 323 
possible  that  the outcomes were not missing at random (as required for multiple imputation).  324 
 325 
Other limitations apply to the use of causal inference methodology rather than an RCT to 326 
evaluate treatment effectiveness. Our confidence in the findings is dependent on the extent to 327 
which there is evidence to support assumptions. There may have been unmeasured confounders, 328 
including for example, unknown reasons for therapists choosing to use AdvTx.  In particular, it is 329 
possible that patients who showed some initial benefit from AdvTx or who made unexpectedly 330 
fast progress were more likely to receive additional AdvTx.  While the propensity score 331 
methodology controlled for confounders associated with the recovery trajectory, it is notable that 332 
the 3 variables that were least balanced by IPW are often strong predictors of rehabilitation 333 
outcomes (FIM Motor and Cognitive at admission and days from injury to rehabilitation).   Our 334 
use of double-adjustment for unbalanced covariates should substantially reduce the influence of 335 
these unbalanced confounders.41  However caution should be exercised in inferring causality. 336 
The analysis of heterogeneity of treatment effects requires particular caution in interpretation 337 
because the number of unbalanced confounders was substantial and it was not possible to include 338 
all in the outcome models. 339 
 340 
While uncontrolled confounding may have inflated effect sizes, the method used for 341 
operationalizing AdvTx may have attenuated effect sizes.  The categorization of a therapy 342 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Advanced Therapy in TBI Rehabilitation 
 16 
segment as Advanced vs. non-Advanced was based on post-hoc sorting of POC entries, not on 343 
direct observation of the session. It is quite possible that the particular setting, instructions, 344 
feedback, and other ingredients selected by the therapist made a segment AdvTx, but was 345 
categorized as non-Advanced because we lacked some of these details on the POC forms. A 346 
prospective study with a carefully planned a priori categorization of treatment segments along 347 
the non-Advanced to Advanced dimension could result in increased effect sizes. 348 
 349 
Conclusions 350 
The findings suggest inpatient TBI rehabilitation patients, especially those presenting with the 351 
most severe level of disability, may benefit from tasks that target the highest level cognitive and 352 
physical functions. These findings are consistent with recent literature indicating that challenging 353 
patients in engaging tasks can lead to cortical reorganization and optimized outcomes.  354 
 355 
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Table 1. Selected confounding variables: minimum and maximum quantile values, average 
standardized differences between quantiles before and after inverse probability weighting. 
  
Prior IPW 
Minimum 
Prior IPW 
Maximum 
Prior 
IPW 
ASD 
After 
IPW ASD 
DEMOGRAPHICS 
 
  
Age at admission mean (SD) 36.6 (16.5) 50.98 (22.59) 0.31 0.12 
Sex: Male 66.3% 78.8% 0.11 0.09 
Race: White 72.1% 78.8% 0.05 0.10 
Race: White Hispanic 3.8% 8.1% 0.07 0.13 
Race: Black 13.0% 19.0% 0.04 0.11 
Race: Asian, Other or Unknown 2.16 4.89% 0.05 0.06 
Education: High School+    65.76% 65.76% 0.11 0.15 
Payer: Private insurance, MCO, HMO 33.5% 56.3% 0.19 0.07 
Payer: Medicare 6.6% 38.0% 0.31 0.10 
Payer: Medicaid 12.0% 22.7% 0.11 0.10 
Payer: Self, Other, None 10.6% 25.1% 0.14 0.12 
  
 
  
PREMORBID CONDITIONS 
 
  
Preinjury Alcohol Misuse 23.5% 49.7% 0.17 0.08 
Preinjury Other Drug Use 11.2% 31.2% 0.18 0.11 
  
 
  
INJURY AND STATUS AT 
REHABILITATION ADMISSION 
 
  
Cause of Injury: Fall 22.3% 39.7% 0.16 0.08 
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Cause of Injury: Moving Vehicle Crash 50.8% 65.2% 0.12 0.06 
Cause of Injury: Violence 3.9% 8.7% 0.08 0.13 
Cause of Injury: Sports and other causes 2.7% 9.2% 0.09 0.12 
Shorter session site 46.2% 87.4% 0.38 0.17 
Time to Rehabilitation Admission mean 
days (SD) 16.04 (11.79) 56.25 (64.83) 0.38 0.21 
FIM (Rasch) Motor-Admission mean 
(SD) 14.33 (15.95) 46.71 (9.62) 0.79 0.30 
FIM (Rasch) Cognitive- Admission mean 
(SD) 21.98 (22.49) 46.99 (12.2) 0.51 0.20 
Post-traumatic amnesia cleared prior to 
rehab 13.4% 60.7% 0.38 0.18 
GCS: Intubated/Missing 36.6% 58.7% 0.17 0.09 
GCS: Mild (13-15) 5.0% 20.8% 0.13 0.08 
GCS: Moderate-Severe (3-12) 33.7% 45.4% 0.10 0.08 
ASD: Average standardized difference; IPW: Inverse probability weighting; Bold indicates ASD 
> .10 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 2.  Adjusted* model for effect of Advanced Therapy, full cohort 
 
Outcome Time Point N 
Average 
Difference 
Lower 95% 
CI 
Upper 95% 
CI 
p-value 
PART-O Total Rasch 3-Month 1442 0.089 0.035 0.142 0.001 
PART-O Total Rasch 9-Month 1383 0.130 0.069 0.191 0.000 
              
PART-O Total 3-Month 1602 0.007 0.002 0.012 0.005 
PART-O Total 9-Month 1519 0.009 0.005 0.013 0.000 
              
PART-O Out-and-About 3-Month 1604 0.007 -0.001 0.014 0.072 
PART-O Out-and-About 9-Month 1523 0.009 0.002 0.015 0.007 
              
PART-O Productivity 3-Month 1609 0.009 0.004 0.013 0.000 
PART-O Productivity 9-Month 1526 0.014 0.008 0.020 0.000 
              
PART-O Social Relations 3-Month 1605 0.005 -0.001 0.011 0.073 
PART-O Social Relations 9-Month 1520 0.003 -0.002 0.008 0.227 
              
FIM Cognitive Rasch Discharge 1826 0.153 0.064 0.242 0.001 
FIM Cognitive Rasch 3-Month 1526 0.163 0.040 0.285 0.010 
FIM Cognitive Rasch 9-Month 1428 0.256 0.148 0.364 0.000 
              
FIM Motor Rasch Discharge 1826 0.299 0.238 0.359 0.000 
FIM Motor Rasch 3-Month 1512 0.313 0.209 0.416 0.000 
FIM Motor Rasch 9-Month 1409 0.347 0.247 0.446 0.000 
              
Satisfaction With Life 3-Month 1200 0.058 -0.021 0.137 0.148 
Satisfaction With Life 9-Month 1218 0.074 0.001 0.148 0.048 
              
PHQ-9 ^ 3-Month 946 0.967 0.946 0.989 0.003 
PHQ-9 ^ 9-Month 1213 0.975 0.955 0.995 0.016 
Bold indicates p<.05; SWLS= Satisfaction with Life Scale; PHQ-9=Patient Health 
Questionnaire-9. ^Odds ratio; the reference group is “not depressed”.  *Adjusted for: age, race 
(white Hispanic, black), marital status (single, married) lived with (alone, significant other, 
family other than spouse, non-family member), retired, high school or greater education, pre-
injury driver, payer private, managed care organization or health maintenance organization, 
previous brain injuries (none, one or two+), premorbid other drug use, premorbid impulse control 
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problems, prior adult central nervous system disorder, premorbid pain problems, cause of injury 
(sports/other, violence) shorter session site, days injury to rehabilitation admission, FIM Motor, 
FIM Cognitive, CSI Brain Injury, CSI Non-Brain Injury, craniotomy, post-traumatic amnesia 
status at admission, open head injury with contusion/hemorrhage, facial fracture, skull fracture, 
weight-bearing precautions, moderate-severe aphasia, paralysis at admission. 
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Table 3. Adjusted* Model for Interaction of Initial Severity and Proportion of Advanced Therapy  
 
      ---------- Severe ------------- -------- Not Severe -------- Interaction 
p-value 
Outcome Time Point N Effect Lower 95% CI 
Upper 
95% CI Effect 
Lower 
95% CI 
Upper 
95% CI 
PART-O Total Rasch 3-Month 1442 0.130 0.028 0.231 0.082 0.020 0.145 0.42 
PART-O Total Rasch 9-Month 1385 0.169 0.090 0.248 0.121 0.060 0.182 0.33 
    
PART-O Total 3-Month 1602 0.006 -0.001 0.013 0.008 0.002 0.013 0.67 
PART-O Total 9-Month 1521 0.010 0.003 0.017 0.009 0.004 0.013 0.76 
    
PART-O Out-and-
About 3-Month 1604 0.009 0.000 0.018 0.008 0.001 0.015 0.79 
PART-O Out-and-
About 9-Month 1525 0.010 0.001 0.019 0.009 0.002 0.015 0.83 
    
PART-O Productivity 3-Month 1609 0.006 0.000 0.013 0.008 0.003 0.014 0.64 
PART-O Productivity 9-Month 1528 0.017 0.007 0.027 0.011 0.005 0.018 0.29 
    
PART-O Social 3-Month 1605 0.002 -0.008 0.013 0.007 0.000 0.014 0.46 
PART-O Social 9-Month 1522 0.003 -0.008 0.014 0.006 -0.001 0.012 0.66 
    
FIM Cognitive Rasch Discharge 1827 0.483 0.390 0.576 0.012 -0.088 0.113 0.00 
FIM Cognitive Rasch 3-Month 1526 0.414 0.229 0.600 0.050 -0.066 0.166 0.00 
FIM Cognitive Rasch 9-Month 1430 0.400 0.179 0.620 0.055 -0.057 0.167 0.01 
    
FIM Motor Rasch Discharge 1827 0.580 0.477 0.683 0.235 0.176 0.295 0.00 
FIM Motor Rasch 3-Month 1512 0.605 0.414 0.794 0.198 0.090 0.306 0.00 
FIM Motor Rasch 9-Month 1411 0.532 0.337 0.726 0.249 0.143 0.355 0.01 
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SWLS 3-Month 1200 0.077 -0.029 0.182 0.116 0.028 0.203 0.55 
SWLS 9-Month 1220 0.040 -0.074 0.155 0.082 0.009 0.155 0.54 
    
PHQ-9^ 3-Month 946 0.998 0.961 1.037 0.964 0.939 0.989 0.13 
PHQ-9^ 9-Month 1215 0.981 0.948 1.014 0.982 0.960 1.004 0.94 
                      
^Odds ratio, the reference group is “not depressed”; SWLS=Satisfaction with Life Scale; PHQ-9=Patient Health 
Questionnaire-9,  *Adjustment covariates:  days from injury to rehabilitation admission, FIM Cognitive, CSI Brain Injury, 
prior brain injury (none or 2+), payer (Medicaid, Medicare, private/MCO/HMO, or other/self/none), craniectomy, craniotomy, 
moderate-severe aphasia,  post-traumatic amnesia at admission, shorter session site, weight-bearing precautions, race (white, 
black), prior adult central nervous system disorder, Glasgow Coma Scale 9-12; paralysis; injury cause (violence, sports/other), 
subdural hematoma, midline shift (none, 0 to 5 mm, not otherwise specified, unknown) premorbid driver, open head injury 
with contusion/hemorrhage, closed head injury with no contusion/hemorrhage, maximum pain score first 3 days, epidural 
hematoma, lived with non-family member, high school+ education; skull fracture, previous living situation, sex male, retired, 
intraventricular hemorrhage, premorbid learning disorder, premorbid difficulties with activities of daily living.   
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Assessed for Eligibility (N=2130) 
Excluded (n= 287) 
• Did not meet original criterion of first 
rehab admission (n=10) 
• Not US site (Canadian n=149) 
• Did not consent to follow-up (n=127) 
• No therapy after 1st 3 days of 
admission (n=1) 
•    
Eligible for Follow-up 
(n=1843) 
Not followed at 3 months (n=220) 
• Withdrew/refused (n=38) 
• Deceased (n=33) 
• Incarcerated (n=6) 
• Lost to follow-up (n=133) 
• Not followed d/t site (n=10) 
Not followed at 9 months (n=301) 
• Withdrew/refused (n=46) 
• Deceased (n=79) 
• Incarcerated (n=9) 
• Lost to follow-up (n=117) 
• Not followed d/t site (n=50) 
 
Samples Available for Analysis After Removal of Missing Items 
 
FIM at discharge n=1843 
Objective measures at 3 months n=1523-1622 
Subjective measures at 3 months n=1176-1211 
Objective measures at 9 months n=1423-1541 
Subjective measures at 9 months n=1200-1231 
 
 
